Citi Upgrades Novavax (NVAX) to Buy

March 1, 2018 8:42 AM

Citi upgraded Novavax (NASDAQ: NVAX) from Neutral to Buy with a price target of $3.50 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found